Balyasny Asset Management Upped Its Boston Scientific (BSX) Stake; Costain Group plc (LON:COST) Had 5 Bulls

February 23, 2018 - By Dolores Ford

Among 6 analysts covering Costain Group PLC (LON:COST), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Costain Group PLC had 63 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of Costain Group plc (LON:COST) has “Buy” rating given on Wednesday, August 24 by Liberum Capital. Peel Hunt maintained Costain Group plc (LON:COST) rating on Thursday, January 5. Peel Hunt has “Buy” rating and GBX 450 target. The firm earned “Buy” rating on Wednesday, July 6 by Liberum Capital. On Friday, September 29 the stock rating was maintained by Liberum Capital with “Buy”. The stock has “Buy” rating by Beaufort Securities on Thursday, January 7. The company was maintained on Thursday, March 3 by Beaufort Securities. The company was maintained on Monday, October 10 by Peel Hunt. The rating was maintained by Liberum Capital with “Buy” on Wednesday, May 4. The firm has “Buy” rating given on Wednesday, August 30 by Liberum Capital. Liberum Capital maintained it with “Buy” rating and GBX 420 target in Wednesday, January 6 report. See Costain Group plc (LON:COST) latest ratings:

23/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 500.00 New Target: GBX 500.00 Maintain
04/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 500.00 New Target: GBX 500.00 Maintain
04/01/2018 Broker: Liberum Capital Rating: Buy Old Target: GBX 545.00 New Target: GBX 545.00 Maintain
14/12/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 545.00 New Target: GBX 545.00 Maintain
10/11/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 545.00 New Target: GBX 545.00 Maintain
31/10/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 510.00 New Target: GBX 510.00 Maintain
29/09/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 510.00 New Target: GBX 510.00 Maintain
30/08/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 510.00 New Target: GBX 545.00 Maintain
24/08/2017 Broker: Jefferies Rating: Buy Old Target: GBX 500.00 New Target: GBX 560.00 Upgrade
24/08/2017 Broker: Beaufort Securities Rating: Buy Maintain




Balyasny Asset Management Llc increased Boston Scientific Corp (BSX) stake by 145.48% reported in 2017Q3 SEC filing. Balyasny Asset Management Llc acquired 581,924 shares as Boston Scientific Corp (BSX)’s stock rose 4.02%. The Balyasny Asset Management Llc holds 981,924 shares with $28.64 million value, up from 400,000 last quarter. Boston Scientific Corp now has $36.68B valuation. The stock increased 0.87% or $0.23 during the last trading session, reaching $26.71. About 2.60 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since February 23, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Balyasny Asset Management Llc decreased Bunge Ltd (NYSE:BG) stake by 201,807 shares to 48,193 valued at $3.35 million in 2017Q3. It also reduced Walt Disney Co/The (Put) (NYSE:DIS) stake by 60,000 shares and now owns 100,000 shares. Spirit Aerosystems Holdings Inc (NYSE:SPR) was reduced too.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It improved, as 33 investors sold BSX shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. Price T Rowe Assocs Md holds 2.41 million shares. Sit Associate Inc has invested 0.1% in Boston Scientific Corporation (NYSE:BSX). State Of Alaska Department Of Revenue holds 0.06% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 39,410 shares. Moneta Grp Incorporated Investment Advsr Ltd Limited Liability Company reported 10,440 shares. Private Advisor Gru Limited Liability Corp stated it has 0.01% in Boston Scientific Corporation (NYSE:BSX). Livforsakringsbolaget Skandia Omsesidigt holds 0.07% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 25,947 shares. Aperio Grp Limited Co reported 516,577 shares stake. Johnson Fin Incorporated holds 687 shares. Glenmede Na reported 24,645 shares. First Personal Financial Svcs owns 9,107 shares. 194,097 were accumulated by First Fincl Bank Of Omaha. Cornerstone Cap Mngmt Hldg Ltd Company holds 0.05% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 235,258 shares. Welch And Forbes Limited Liability Company reported 0.31% stake. Clough Capital Prns Limited Partnership invested in 0.5% or 257,400 shares. 66,435 were accumulated by Amica Mutual Com.

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 89 analyst reports since July 27, 2015 according to SRatingsIntel. On Wednesday, November 29 the stock rating was maintained by Stifel Nicolaus with “Buy”. The stock of Boston Scientific Corporation (NYSE:BSX) has “Buy” rating given on Thursday, July 27 by Needham. The rating was maintained by Needham with “Buy” on Thursday, June 22. Stifel Nicolaus maintained Boston Scientific Corporation (NYSE:BSX) rating on Thursday, April 28. Stifel Nicolaus has “Buy” rating and $25 target. The stock of Boston Scientific Corporation (NYSE:BSX) has “Buy” rating given on Wednesday, June 28 by Barclays Capital. The rating was maintained by FinnCap on Thursday, October 29 with “Corporate”. The firm has “Buy” rating by Needham given on Friday, July 29. The firm earned “Buy” rating on Wednesday, October 28 by Needham. The rating was maintained by Jefferies on Tuesday, June 27 with “Hold”. Wedbush maintained the stock with “Neutral” rating in Friday, July 29 report.

Since August 29, 2017, it had 0 insider buys, and 12 selling transactions for $16.75 million activity. 15,500 Boston Scientific Corporation (NYSE:BSX) shares with value of $440,547 were sold by Phalen Michael P.. 10,104 shares were sold by Pratt Timothy A., worth $277,475. Fitzgerald Joseph Michael sold 85,227 shares worth $2.26 million. Another trade for 5,152 shares valued at $139,104 was made by Pierce David A on Tuesday, January 9. Nanavaty Maulik sold $1.56M worth of Boston Scientific Corporation (NYSE:BSX) on Wednesday, August 30. On Tuesday, October 3 the insider Bose Supratim sold $10.11M.

Costain Group Plc provides engineering solutions for various energy, water, and transportation infrastructures in the United Kingdom, Spain, and internationally. The company has market cap of 470.38 million GBP. It operates in two divisions, Natural Resources and Infrastructure. It has a 16.08 P/E ratio. The Natural Resources segment engages in the water, power, and gas and oil markets.

Since September 1, 2017, it had 0 insider buys, and 16 selling transactions for $22.37 million activity. SINEGAL JAMES D sold $5.76 million worth of stock or 30,000 shares. $3.86M worth of Costain Group plc (LON:COST) shares were sold by LIBENSON RICHARD M. 5,000 shares were sold by ZOOK DENNIS R, worth $810,788 on Wednesday, October 25. $1.31 million worth of Costain Group plc (LON:COST) was sold by MOULTON PAUL G. On Monday, January 8 Vachris Roland Michael sold $977,510 worth of Costain Group plc (LON:COST) or 5,200 shares. GALANTI RICHARD A also sold $802,892 worth of Costain Group plc (LON:COST) shares. Hines Daniel M. sold $943,080 worth of stock.

It closed at GBX 445.5 lastly. It is down 0.00% since February 23, 2017 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.